We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Histologic Features Guide Prognosis of Childhood Medulloblastomas

By LabMedica International staff writers
Posted on 20 Nov 2008
Specific histologic features of childhood tumors called medulloblastomas may provide insight into prognoses. More...


Medulloblastomas are common, malignant, embryonal tumors in the cerebellum. Individual histologic features such as nodules, balls, or high cell density are used to divide the tumors into variants thought to modify survival estimates.

Scientists found a difference in survival distribution for six features of medulloblastomas: high cell density, fine fibrillary stroma, necrosis, nodules, balls, and prominent nucleoli. The presence of nodules, balls, fine fibrillary stroma, and high cell density improved the survival outlook, whereas necrosis and prominent nucleoli worsened it.

The World Health Organization (WHO; Geneva, Switzerland) classification of these tumors includes desmoplastic/nodular (DM), medulloblastoma with extensive nodularity (N), large cell medulloblastoma (LC), and anaplastic medulloblastoma (A).

"The presence of nodularity in medulloblastoma is important to improved survival likelihood, particularly when combined with balls and fine fibrillary stroma,” wrote Dr. Floyed H. Giles M.D. from the neuropathology department at the Children's Hospital, Los Angeles, (Los Angeles, CA, USA) and colleagues in an article published in the November 13, 2008, issue of the journal Pediatric and Developmental Pathology. "Given the WHO-acknowledged ‘overlap' of desmoplastic/nodular medulloblastoma and nodular medulloblastoma, we suggest these diagnoses be combined into a diagnosis of nodular medulloblastoma, with nodules, balls, and fine fibrillary stroma as defining criteria.”

The investigators contend that three histologic features vital for LC and A diagnoses--large and intermediate size nuclei and prominent nucleoli--have poor read-reread reliability and suggest these be combined into a diagnosis of anaplastic/large cell medulloblastoma.

Related Links:
World Health Organization
Children's Hospital Los Angeles



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.